Camenisch G, Folkers G, van de Waterbeemd H
F. Hoffmann-La Roche Ltd., Pharma Research-New Technologies, Basel, Switzerland.
Pharm Acta Helv. 1996 Nov;71(5):309-27. doi: 10.1016/s0031-6865(96)00031-3.
In the drug discovery process the optimization of a promising lead to an orally bioavailable drug remains a difficult task. Recent progress in the understanding of the role of physicochemical properties in membrane permeability relevant to important processes such as drug absorption and blood-brain barrier crossing, brings rational drug delivery more within reach. In the last thirty years a number of theoretical transport and absorption models have been developed to describe mathematically how a drug is being passively transported from its site of administration to its site of action and how a compound passes a membrane. The goal of such models is to rationalize the physical significance of the observed non-linear structure-permeability relationships. The models are based on various views on the composition of the biological membranes and on the underlying diffusion and distribution mechanisms. Often simplifications reducing the mathematical complexity are made. We review here a selection of the most important models and discuss modern views on the role of lipophilicity and various pathways through membranes.
在药物发现过程中,将有前景的先导化合物优化为口服生物利用度高的药物仍然是一项艰巨的任务。在理解物理化学性质在与药物吸收和血脑屏障穿越等重要过程相关的膜通透性中的作用方面取得的最新进展,使合理的药物递送更易于实现。在过去三十年中,已经开发了许多理论转运和吸收模型,以数学方式描述药物如何从给药部位被动转运到作用部位,以及化合物如何穿过膜。此类模型的目标是使观察到的非线性结构-通透性关系的物理意义合理化。这些模型基于对生物膜组成以及潜在扩散和分布机制的各种观点。通常会进行简化以降低数学复杂性。我们在此回顾一些最重要的模型,并讨论关于亲脂性的作用以及穿过膜的各种途径的现代观点。